The application of in vivo confocal scanning laser microscopy in the management of Acanthamoeba keratitis

Molecular Vision

Volumn 13, Issue , 2007, Pages 1319-1326

  Matsumoto, Yukihiro ^a   Dogru, Murat ^a,b   Sato, Enrique Adan ^a   Katono, Yasuhiro ^a   Uchino, Yuichi ^a   Shimmura, Shigeto ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE; CONTACT LENS SOLUTION; FLUCONAZOLE; FUNGARD; MASKIN WATER; MICAFUNGIN; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; CASE REPORT; CASE STUDY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; CONFOCAL LASER MICROSCOPY; CORNEA EDEMA; CORNEA EPITHELIUM; CYST; EYE PAIN; FEMALE; HUMAN; IN VIVO STUDY; INTERVENTION STUDY; JAPAN; MALE; PRIORITY JOURNAL; SLIT LAMP; SOFT CONTACT LENS; TREATMENT RESPONSE; TROPHOZOITE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADULT; ANIMALS; CELLS, CULTURED; CORNEA; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; VISUAL ACUITY;

EID: 34547530825     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol 2006; 142:212-7.
2. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 2002; 86:536-42.
3. Seal DV, Kirkness CM, Bennett HG, Peterson M, Keratitis Study Group. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye 1999; 22:49-57.
4. Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E, Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 2002; 16:608-18.
5. Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol 1998; 82:1387-92.
6. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 1998; 17:3-10.
7. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003; 17:893-905.
8. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006; 17:327-31.
9. Babu K, Murthy KR. Combined fungal and acanthamoeba keratitis: diagnosis by in vivo confocal microscopy. Eye 2007; 21:271-2.
10. Alizadeh H, Niederkorn JY, McCulley JR. Acanthamoeba keratitis. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. Vol 1. Philadelphia: Elsevier Mosby; 2005. p. 1115-22.
11. Kaufman SC, Musch DC, Belin MW, Cohen EJ, Meisler DM, Reinhart WJ, Udell IJ, Van Meter WS. Confocal microscopy: a report by the American Academy of Ophthalmology. Ophthalmology 2004; 111:396-406. Erratum in: Ophthalmology. 2004; 111:1306.
12. Cho BJ, Holland EI. In vivo tandem scanning confocal microscopy in acanthamoeba keratitis. Korean J Ophthalmol 1998; 12:112-7.
13. Mathers WD, Nelson SE, Lane JL, Wilson ME, Allen RC, Folberg R. Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. Arch Ophthalmol 2000; 118:178-83.
14. Parmar DN, Awwad ST, Petroll WM, Bowman RW, McCulley JP, Cavanagh HD. Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology 2006; 113:538-47.
15. Winchester K, Mathers WD, Sutphin JE, Daley TE. Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy. Cornea 1995; 14:10-7.
16. Bharathi MJ, Ramakrishnan R, Meenakshi R, Mittal S, Shivakumar C, Srinivasan M. Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results. Br J Ophthalmol 2006; 90:1271-6.
17. Yera H, Zamfir O, Bourcier T, Ancelle T, Batellier L, Dupouy-Camet J, Chaumeil C. Comparison of PCR, microscopic examination and culture for the early diagnosis and characterization of Acanthamoeba isolates from ocular infections. Eur J Clin Microbiol Infect Dis 2007; 26:221-4.
18. Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996; 10:413-21.
19. Perez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Ophthalmology 2003; 110:1593-600.
20. Sun X, Zhang Y, Li R, Wang Z, Luo S, Gao M, Deng S, Chen W, Jin X. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006; 113:412-6.
21. van der Bijl P, van Eyk AD, Seifart HI, Meyer D. In vitro transcorneal penetration of metronidazole and its potential use as adjunct therapy in Acanthamoeba keratitis. Cornea 2004; 23:386-9.
22. Bouyer S, Imbert C, Daniault G, Cateau E, Rodier MH. Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba. J Antimicrob Chemother 2007; 59:122-4.
23. Kaji Y, Hiraoka T, Oshika T. Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis. Cornea 2004; 23:S36-41.
24. Matsumoto Y, Dogru M, Goto E, Fujishima H, Tsubota K. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review. Cornea 2005; 24:748-53.